Novel Drugs by Biotransformation—in Memory of the Late Scientists Frieder Schauer and Peter Grunwald
A special issue of Microorganisms (ISSN 2076-2607). This special issue belongs to the section "Microbial Biotechnology".
Deadline for manuscript submissions: closed (30 December 2022) | Viewed by 13383
Special Issue Editors
Interests: biotransformation; drugs; antibiotics; laccase
Special Issues, Collections and Topics in MDPI journals
Interests: plant secondary metabolism; biosynthesis and biotechnology of polyprenylated aromatic polyketides; transgenesis; plant tissue culture; biosynthesis of benzoic acid-based phytoalexins such as xanthones and biphenyls
Special Issues, Collections and Topics in MDPI journals
Special Issue Information
Dear Colleagues,
Isolated enzymes or whole microbial cells are environmentally friendly catalysts which can be used in aqueous solution at room temperature, atmospheric pressure, and moderate pH values and are therefore well suited for the green synthesis of novel drugs. Microbial enzymes transform numerous substances in a reaction-, region-, and stereospecific way and thus in many cases may meet the requirements of modern drug synthesis. Of particular practical value is the fact that they not only catalyze the reactions of their natural substrates but also convert other compounds. Biotechnological processes use whole cells and/or specific enzymes. Biosynthetic processes, which often require a cascade of individual enzyme reactions, are usually carried out with whole cells, whereas biotransformation reactions use either isolated enzymes or whole cells depending on the properties of the enzymes involved. When evaluating a process, the advantages and disadvantages of isolated enzymes and whole cells must be weighed against each other, though where possible, specific enzymes tend to be preferred so as to exclude side reactions catalyzed by cells. This Special Issue will provide an insight into strategies of biosynthesis and biotransformation of novel drugs. The latest proven enzyme-mediated routes, using single-step biotransformation or enzyme cascade synthesis, will be discussed.
Dr. Annett Mikolasch
Dr. Mariam Gaid
Guest Editors
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Microorganisms is an international peer-reviewed open access monthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2700 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- biosynthesis
- biotransformation
- drugs
- enzyme cascade synthesis
- green synthesis
- environmentally friendly catalyst